Drexel Morgan & Co.’s Cvs Health Corp Position
Does Drexel Morgan & Co. own Cvs Health Corp (CVS)? Not currently — the last reported position was 600.2K shares worth $27M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$27M
Q4 2024
Shares
600.2K
% of Portfolio
+5.56%
Quarters Held
23
position exited
Position History CVS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 600.2K | $27M | +5.56% |
| Q3 2024 | 200.2K | $13M | +2.34% |
| Q2 2024 | 200.2K | $12M | +2.53% |
| Q1 2024 | 100.3K | $8M | +1.65% |
| Q4 2023 | 100.1K | $8M | +1.83% |
| Q3 2023 | 100.0K | $7M | +1.90% |
| Q2 2023 | 100.0K | $7M | +1.79% |
| Q1 2023 | 100.0K | $7M | +1.87% |
| Q4 2022 | 100.0K | $9M | +1.92% |
| Q3 2022 | 100.0K | $10M | +2.29% |
| Q2 2022 | 100.0K | $9M | +2.55% |
| Q1 2022 | 100.0K | $10M | +2.94% |
| Q4 2021 | 100.0K | $10M | +2.98% |
| Q3 2021 | 100.0K | $8M | +2.73% |
| Q2 2021 | 100.0K | $8M | +2.46% |
| Q1 2021 | 100.1K | $8M | +1.91% |
| Q2 2020 | 3.6K | $236,000 | +0.09% |
| Q1 2020 | 3.6K | $215,000 | +0.08% |
| Q4 2019 | 3.6K | $270,000 | +0.20% |
| Q3 2019 | 3.6K | $229,000 | +0.18% |
| Q2 2019 | 4.0K | $216,000 | +0.17% |
| Q1 2019 | 4.0K | $214,000 | +0.19% |
| Q4 2018 | 4.0K | $260,000 | +0.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Drexel Morgan & Co.’s full portfolio or all institutional holders of CVS.